Precision BioSciences gets FDA orphan drug designations for DMD treatment

Go back to Precision BioSciences gets FDA orphan drug designations for DMD treatment
(NASDAQ: DTIL) Delayed: 8.85 +0.13 (1.49%)
Previous Close $8.72    52 Week High
Open $8.81    52 Week Low
Day High $9.08    P/E N/A 
Day Low $8.63    EPS
Volume 305,181